Search for: "Apotex, Inc. "
Results 361 - 380
of 672
Sort by Relevance
|
Sort by Date
9 Nov 2011, 9:59 pm
("Apotex"); and affirmed the District Court's holding that Apotex Inc. is jointly and severally liable for all damages. [read post]
18 Oct 2011, 8:31 am
Apotex Inc., 748 F. [read post]
13 Oct 2011, 7:45 pm
Apotex, Inc., 470 F.3d 1368, 1374 (Fed. [read post]
7 Sep 2011, 4:22 am
Highlights this week included: US: CAFC: Immunisation methods are patent eligible: Classen Immunotherapies, Inc v Biogen IDEC et al (Inventive Step) (Orange Book Blog) (Patently-O) (Patent Docs) (Patent Docs) (IPBiz) (Patent Law Practice Center) (Patent Baristas) US: FTC issues long-awaited final report on authorized generics; report examines both the short-term effects and long-term impact on competition and drug prices (FDA Law Blog) (Orange Book Blog) Please join the… [read post]
30 Aug 2011, 10:07 pm
Apotex, Inc. [read post]
28 Aug 2011, 9:57 pm
• Defendants: Apotex Inc.; Apotex Corp. [read post]
27 Aug 2011, 7:55 pm
Ortho-McNeil Pharm., Inc. [read post]
25 Aug 2011, 9:59 pm
Apotex, Inc. [read post]
25 Aug 2011, 8:14 am
See Walker-Process Equip., Inc. v. [read post]
25 Aug 2011, 8:14 am
See Walker-Process Equip., Inc. v. [read post]
24 Aug 2011, 9:00 pm
Apotex, Inc., 470 F.3d 1368, 1375 (Fed. [read post]
10 Aug 2011, 4:30 am
(Patent Docs) Relpax (Eletripian hydrobromide) – Pfizer settles Relpax infringement suit with Apotex (Patent Docs) Solodyn (Minocycline) – US: Medicis and Lupin settle Solodyn infringement dispute; Agree to drug development collaboration (Patent Docs) Viagra (Sildenafil citrate) – US: Patent infringement complaint filed following a Paragraph IV certification: Pfizer Inc. et al. v. [read post]
4 Aug 2011, 7:40 am
Apotex Corp., 439 F.3d 1312, 1319 (Fed. [read post]
3 Aug 2011, 3:31 am
Application fee increases by a whopping 19.4% (or almost $300K) (FDA Law Blog) US: Life sciences venture funding up 37% in second quarter (Patent Docs) Products Arava (Leflunomide) – Australia: FCA ‘evergreens’ Arava: Sanofi-Aventis Australia v Apotex (Patentology) Cambia (Diclofenac) – US: Nautilus files patent infringement complaint against Edict Pharmaceuticals in response to Para IV certification filing (Patent Docs) Cenestin – US: CAFC affirms… [read post]
1 Aug 2011, 8:19 am
The seven defendants, Actavis Elizabeth LLC, Sun Pharmaceuticals, Sandoz Inc., Mylan Pharmaceuticals, Apotex Inc., Aurobindo Pharma Ltd., and Teva Pharmaceuticals, had filed an Abbreviated New Drug Application (ANDA) seeking to utilize Lilly's patented formula and claiming invalidity of Lilly's patent, No. 5,658,590, Treatment of attention-deficit/hyperactivity disorder, which has been issued by the US Patent Office. [read post]
27 Jul 2011, 4:06 pm
The court granted leave to file briefs amici curiae to Teva Pharmaceuticals, USA, Inc., Mylan Pharmaceuticals Inc., Apotex Inc. and Impax Laborato- ries, Inc., Consumer Federation of America and National Legislative Association on Prescription Drug Prices, and Generic Pharmaceutical Association.The petition for rehearing was considered by the panel that heard the appeal, and thereafter the petition for rehearing en banc, the response to the petition, and… [read post]
20 Jul 2011, 4:04 am
: Supreme Court hearing Human Genome Sciences Inc v Eli Lilly and Company (IPKat) Nexium (Esomeprazole) – UK: EWHC: Ranbaxy wins declaration of non-infringement: Ranbaxy v AstraZeneca (IPKat) Olanzapine – Spain: Supreme Court hands down landmark judgment on doctrine of equivalents and TRIPS (Kluwer Patent Blog) OxyContin (Oxycodone) – US: Purdue files patent infringement suit against Sandoz in response to Para IV certification (Patent Docs) Prevacid (Lansoprazole) –… [read post]
29 Jun 2011, 3:34 am
Apotex Inc. et al. [read post]
29 Jun 2011, 2:00 am
Eagle Innovations, Inc., (Case No. 10-cv-02850REB (D. [read post]
29 Jun 2011, 2:00 am
Eagle Innovations, Inc., (Case No. 10-cv-02850REB (D. [read post]
